Aaron Lisberg

11PUBLICATIONS
103CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 25, 2026
Evaluating datopotamab deruxtecan (Dato-DXd) as a novel treatment option for EGFR-mutated non-small cell lung cancer.

|Dec 09, 2025
Macropinocytosis and Vascularization Determine Response to mTOR Inhibitors in Lung Squamous Cell Carcinoma.

Morgan R Brady, Nedas Matulionis, Heather R Christofk

|Sep 10, 2025
Identification of Targetable EGFR Mutations in Ovarian Cancer.

Arjan Gower, Susan Win, Rituparna Ganguly

|Jun 02, 2025
Adequacy of Immune Checkpoint Inhibitor-Associated Thyroid Function Monitoring After Therapy.

Maria A Velez, Elliot S Kang, Chester A Thompson

|Jan 06, 2025
Datopotamab Deruxtecan in Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study.

Jacob Sands, Myung-Ju Ahn, Aaron Lisberg

|Nov 19, 2024
Characteristics of a CCL21 Gene-Modified Dendritic Cell Vaccine Utilized for a Clinical Trial in Non-Small Cell Lung Cancer.

Michael S Oh, Camelia Dumitras, Ramin Salehi-Rad

Pageof 2

Frequent Collaborators

6 joint publications

Edward B Garon

3 joint publications

Jacob Sands

3 joint publications

Maria A Velez

2 joint publications

Toshio Shimizu